Heimar hf.: Regular Notification of Share Buybacks in Accordance with the Buyback Program
- 85
In week 15, Heimar hf. (“Heimar”) purchased 1,645,000 own shares at a total purchase price of 56,164,000 ISK, as follows:
Date | Time | Shares Purchased | Transaction Price (Rate) | Purchase Price (ISK) |
10.4.2025 | 10:16 | 250,000 | 34.4 | 8,600,000 |
10.4.2025 | 11:21 | 10,947 | 34.2 | 374,387 |
10.4.2025 | 11:50 | 500 | 34.2 | 17,100 |
10.4.2025 | 11:50 | 48,334 | 34.2 | 1,653,023 |
10.4.2025 | 11:55 | 48,334 | 34.2 | 1,653,023 |
10.4.2025 | 12:03 | 200 | 34.2 | 6,480 |
10.4.2025 | 12:40 | 5,848 | 34.2 | 200,002 |
10.4.2025 | 13:37 | 200 | 34.2 | 6,840 |
10.4.2025 | 13:59 | 135,637 | 34.2 | 4,638,785 |
11.4.2025 | 09:32 | 145,000 | 33.2 | 4,814,000 |
11.4.2025 | 14:26 | 1,000,000 | 34.2 | 34,200,000 |
Samtals | 1,645,000 | 56,164,000 |
The transactions are in accordance with Heimar’s buyback program, which was announced on April 8, 2025. According to the program, the buybacks will amount to a maximum of ISK 500,000,000 in total, and the program will remain in effect until that limit is reached, but no later than the company’s 2026 Annual General Meeting.
Heimar owned no shares prior to the above transaction, and following these purchases, now holds 1,645,000 shares, or approximately 0.09% of the company’s issued shares, with a total purchase price of ISK 56,164,000.
The execution of the buyback program will comply with the Icelandic Public Limited Companies Act, No. 2/1995, Article 5 of the European Parliament and Council Regulation (EU) No. 596/2014 on Market Abuse, as referred to in the Icelandic Act on Measures Against Market Abuse, No. 60/2021, as well as the European Commission's delegated regulation No. 2016/1052/EU, which contains technical terms related to buyback programs.
Please note that in case of discrepancy in the English and the Icelandic versions, the Icelandic version shall prevail.
For further information, please contact:
Björn Eyþór Benediktsson – Chief Financial Officer – [email protected]

GlobeNewswire ist eines der weltweit größten Nachrichtennetzwerke, das sich auf die Verbreitung von Pressemitteilungen, Finanzinformationen und Multimedia-Inhalten an Medien, Investoren und Leser weltweit spezialisiert hat.
- EQS-News: FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
- FDA-Zulassungsverfahren von Izotropic genehmigt - Unternehmen gibt Update
- EQS-News: pferdewetten.de AG: Wirtschaftsprüfer avisiert Versagungsvermerk für Jahresabschluss und Konzernabschluss 2023
- EQS-Adhoc: pferdewetten.de AG: Wirtschaftsprüfer avisiert Versagungsvermerk für Jahresabschluss und Konzernabschluss 2023
- 435 AMRs transformieren das Werk von Chery in Dalian: ForwardX liefert die größte Just-in-Time-Automatisierung im Automobilbau
- EQS-Adhoc: Allane SE: Deutliche Ergebnisverbesserung im ersten Quartal 2025 und Veröffentlichung der Prognose für das Gesamtjahr 2025